NanoViricides Measles Treatment Gains FDA Orphan Drug Status
The Food and Drug Administration, which first approved a proposed drug for use in emergencies in 2000, stopped requiring in-person visits five years ago. This change affects how the drug is monitored.
Topics
Developing
- 864d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 864d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 864d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 864d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
WTOP Washington DC
“The federal food and drug administration, which first approved the proposed press down for used in-emborgen in 2000, stopped requiring in-person visits five years ago.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade